Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMJ Case Rep ; 16(5)2023 May 02.
Artigo em Inglês | MEDLINE | ID: mdl-37130644

RESUMO

This is a case of a woman in her 70s with treatment-resistant major depression who was admitted psychiatrically for the fifth time in 1.5 years. She had a history of intensive psychotherapy and psychotropic medication trials with poor efficacy. She also had a history of adverse complications to electroconvulsive therapy (ECT) with prolonged seizures and postictal confusion during her third hospitalisation. At her fifth hospitalisation, due to poor response to routine psychiatric treatment, ECT was pursued. We discuss challenges in pursuing ECT and the outcome of the retrial of an acute ECT series, in the context of a paucity of similar literature regarding geriatric depression.


Assuntos
Transtorno Depressivo Maior , Transtorno Depressivo Resistente a Tratamento , Eletroconvulsoterapia , Estado Epiléptico , Feminino , Humanos , Idoso , Transtorno Depressivo Maior/terapia , Eletroconvulsoterapia/efeitos adversos , Psicoterapia , Transtorno Depressivo Resistente a Tratamento/terapia , Resultado do Tratamento
2.
J Psychiatr Pract ; 27(6): 478-482, 2021 11 05.
Artigo em Inglês | MEDLINE | ID: mdl-34768272

RESUMO

BACKGROUND: Emerging research has shown that there may be a subset of patients who develop a first-break psychosis later in life when they are over 60 years of age. Very late-onset schizophrenia-like psychosis (VLOSLP) differs from early-onset schizophrenia in a few very important ways that lead us to believe that there may be a distinct pathologic process involved. METHODS: We present 4 cases of females with psychotic symptoms that first appeared after the patients were 60 years of age. We conducted a literature review and found that our older adult psychiatric unit is not alone in struggling with diagnoses for these individuals. RESULTS: Some of these patients have a disease that will progress to a neurocognitive disorder, but a large group of others will remain cognitively intact. Fortunately, the treatment for both processes is very similar, but studies have shown that patients with VLOSLP will need significantly lower doses of antipsychotics compared with those with early-onset schizophrenia. CONCLUSIONS: It remains unclear if VLOSLP is a unique disorder, a prodrome to dementia, or a different condition that is not yet understood. Further research is needed to develop comprehensive treatment for patients with VLOSLP.


Assuntos
Antipsicóticos , Demência , Transtornos Psicóticos , Esquizofrenia , Idoso , Antipsicóticos/uso terapêutico , Demência/tratamento farmacológico , Feminino , Humanos , Pessoa de Meia-Idade , Transtornos Psicóticos/terapia , Esquizofrenia/tratamento farmacológico
3.
BMJ Case Rep ; 20162016 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-27613262

RESUMO

We present the case of an elderly woman with hypothyroidism and no psychiatric history who presented with new onset of psychosis, paranoia, catatonic features and Capgras syndrome (CS). This case illustrates the spectrum of neuropsychiatric symptoms that may accompany hypothyroidism and the importance of considering thyroid dysfunction as a primary contributor to severe psychiatric symptoms, especially in previously stable patients. We demonstrate the effectiveness of combination levothyroxine and olanzapine, with its favourable cardiac profile, in the treatment of myxoedema madness. Antipsychotics can be weaned once psychiatric symptoms resolve and hormone levels are stabilised.


Assuntos
Antipsicóticos/uso terapêutico , Benzodiazepinas/uso terapêutico , Síndrome de Capgras/etiologia , Catatonia/etiologia , Mixedema/complicações , Tiroxina/uso terapêutico , Idoso , Síndrome de Capgras/tratamento farmacológico , Catatonia/tratamento farmacológico , Feminino , Humanos , Hipotireoidismo , Mixedema/tratamento farmacológico , Mixedema/psicologia , Olanzapina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...